TORONTO (PRWEB) DECEMBER 01, 2021
The FDA has issued two new draft guidance documents on the use and structure of real-world data in regulatory decision-making. While real-world data has been around for many years, in this webinar the xCures speakers will recap the guidance and discuss what this means for the use of real-world data going forward. In particular, they will discuss the key requirements for real-world data to be suitable for regulatory decision-making and how those requirements differ from traditional uses of real-world data.
More at: https://www.prweb.com/releases/implications_of_new_fda_draft_guidance_on_real_world_data_explained_in_upcoming_webinar_hosted_by_xtalks/prweb18364230.htm